“Consultologists,” Costs and Length of Hospital Stays
The sicker you are, the longer your stay in the hospital and the more specialists you see.
That seems logical.
But the correlation between your health...
Reprogrammed Peptides Kill Cancer in Animal Tests
Researchers at Tuskegee University are reprogramming immune cells to kill cancer and halt tumor growth.
Cancerous tumors evade detection and boost their own growth by...
Construction Innovations Deliver Surgical Excellence to Vestavia Hills
Birmingham construction company Brasfield & Gorrie recently delivered to Vestavia Hills a sparkling new community asset in the form of access to quality health...
Disinfectant Made in Montgomery Helps Battle Coronavirus
Performacide, a chlorine dioxide-based viral disinfectant produced by Star brite Inc. in Montgomery, is registered with the U.S. Environmental Protection Agency as a virucide...
UAB Study: Shop Before Buying Orthobiologic Treatment That “May or May Not Work”
The use of orthobiologics is a hot trend in orthopaedics, but new research from the University of Alabama at Birmingham suggests consumers should do...
Promising Anti-Cancer Research at USA Health Mitchell Cancer Institute
A compound discovered at USA Health Mitchell Cancer Institute in Mobile is being evaluated to see whether it can be more effective against aggressive...
Huntsville Hospital Leads in National Health Care Trend
Huntsville Hospital Systems was one of five hospitals in the country that were recently highlighted by Becker's Hospital Review as outstanding examples of the...
Alabama’s Medicaid Limbo
Legislators have become convinced of the net benefits of extending Medicaid, but they’re stuck on the horns of budget earmarking. Maybe the lottery issue, too.
Research Targets Sickle Cell Disease
Medical research being done in Birmingham aims to decrease painful symptoms of sickle cell disease that can have devastating effects on the patient’s health.
Sickle...
A Herpes Virus May Destroy Cancerous Tumors in Children’s Brains
University of Alabama at Birmingham Pediatric Oncologist Gregory Friedman has been awarded a three-year, $750,000 R01 grant for a phase 1 immunotherapy clinical trial...